Providence Therapeutics Enrolls First Patient in World's First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer - The Manila Times
2fuentes distintas
1país
1idioma
06:00detectada el 18/11 (12:00 UTC)
06:22última novedad, 18/11
2noticias
Cadena de publicación
La publicó primero Taiwan News (Malasia) el 18/11 a las 06:00 (12:00 UTC). En 22 min la cubrieron 2 medios de 1 país.
-
06:0018/11, 12:00 UTC
TNTaiwan News news.google.comProvidence Therapeutics Enrolls First Patient in World's First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer - Taiwan News
MY EN Primera
-
06:2218/11, 12:22 UTC
MTThe Manila Times news.google.comProvidence Therapeutics Enrolls First Patient in World's First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer - The Manila Times
MY EN
Datos de esta historia: JSON


/file/attachments/889/ceb977ca2d785adccc507850a8987622_885571.jpg)



